Peptide Guide + Calculator
GHK-Cu Reconstitution Calculator & Guide
Copper-Binding Tripeptide
GHK-Cu is a copper-binding tripeptide widely discussed in skin-care, wound-healing, hair, and tissue-remodeling research. The strongest human evidence is topical and remains limited, while injectable GHK-Cu has no established human safety or efficacy profile. This page explains the evidence, route-specific safety and regulatory context, common claims, and educational reconstitution math.
Evidence Snapshot
GHK-Cu research at a glance
Standardized regulatory and evidence context so research compounds, investigational drugs, and approved medications are not treated as if they have the same level of human evidence.
Regulatory status
Not FDA-approvedDevelopment / evidence stage
Early human evidence — topical route
No established development program
Human evidence level
Very limited human evidencePrimary mechanism
Naturally occurring copper-binding tripeptide associated with extracellular-matrix, collagen, and wound-repair signaling.
WADA context
Non-approved substance — S0 may applyHuman intervention evidence
Topical human evidence should not be generalized to injectable GHK-Cu. Human safety and effectiveness data for injectable use are very limited.
Human biology evidence
GHK-Cu has substantial laboratory biology and some small human topical cosmetic studies involving skin appearance and repair-related outcomes.
Key takeaway
GHK-Cu is a route-dependent evidence story: topical cosmetic evidence exists, but it should not be used to imply injectable efficacy or safety.
Evidence labels describe the research base and regulatory context; they are not treatment, dosing, or use recommendations. Review dates describe the last BACToBasics source check for this evidence summary. Anti-doping rules can change and should be verified with the applicable authority.
GHK-Cu Reconstitution Calculator
Enter the vial amount, liquid volume, and amount you want to calculate. BACToBasics will automatically calculate concentration, liquid volume, and U-100 syringe-unit equivalents.
Loading calculator...
Calculator values are educational math inputs only. They are not recommended preparation amounts, doses, or use protocols.
GHK-Cu Reconstitution Math
Reconstitution math starts with the amount contained in the vial and the liquid volume used in the calculation. Dividing the vial amount by the liquid volume gives the resulting concentration.
Example vial amount
50 mg
| Liquid Volume | Calculation | Concentration |
|---|---|---|
| 1 mL | 50 mg ÷ 1 mL | 50 mg/mL |
| 2 mL | 50 mg ÷ 2 mL | 25 mg/mL |
| 3 mL | 50 mg ÷ 3 mL | 16.6667 mg/mL |
This table demonstrates concentration math only. The liquid volumes shown are examples for comparison and are not preparation recommendations.
More Reconstitution Tools
Need to compare different liquid volumes or convert between mg, mcg, mL, and U-100 units? Use the dedicated BACToBasics calculator tools.
What is GHK-Cu?
GHK-Cu is the copper(II) complex of the naturally occurring tripeptide glycyl-L-histidyl-L-lysine, often abbreviated GHK. GHK can bind copper ions, producing the blue-colored complex commonly called GHK-Cu or Copper Tripeptide-1. It has been studied for effects involving extracellular-matrix remodeling, fibroblast activity, collagen production, wound repair, and other tissue-repair pathways.
GHK vs GHK-Cu
GHK refers to the three-amino-acid peptide itself, while GHK-Cu refers to GHK coordinated with a copper ion. Research and product descriptions sometimes blur these terms, but they are not chemically identical. Evidence involving GHK, GHK-Cu, or other copper-binding peptides should not automatically be treated as interchangeable.
What does laboratory research show?
Much of the mechanistic evidence comes from cell-culture and preclinical studies. Human fibroblast experiments have reported increased collagen synthesis and increased production of certain glycosaminoglycans after exposure to GHK-Cu. These findings support a plausible role in extracellular-matrix remodeling, but laboratory effects do not by themselves establish a clinical benefit in people.
What human evidence exists for skin?
Human evidence is much smaller than online marketing often suggests. In a randomized study of 13 people using copper-tripeptide skin-care products after carbon-dioxide laser resurfacing, objective assessments found no significant advantage for erythema resolution, wrinkles, or overall skin quality compared with the control regimen. Patient-reported satisfaction with skin quality was higher in the GHK-Cu group. The study was small and does not establish broad anti-aging efficacy.
GHK-Cu and collagen
GHK-Cu is commonly discussed for collagen because older human-fibroblast studies found increased collagen synthesis in cell culture. This is biologically interesting and helps explain its use in cosmetic research, but an increase in collagen production in cultured fibroblasts is not equivalent to proving that a topical or injectable product will visibly rebuild skin in humans.
GHK-Cu and wound healing
GHK-Cu has a long preclinical literature involving tissue repair and wound-healing pathways, including fibroblast activity, extracellular-matrix production, angiogenesis-related signaling, and inflammation. However, most direct evidence is laboratory or animal research. Large modern randomized human trials demonstrating faster wound closure or better clinical outcomes are still lacking.
GHK-Cu and hair growth
Copper peptides are frequently marketed for hair growth, but direct clinical evidence for GHK-Cu regrowing human hair is limited. Some often-cited hair-follicle experiments involve related copper peptides such as AHK-Cu rather than GHK-Cu itself. These findings should not be presented as proof that GHK-Cu treats androgenetic alopecia or produces clinically meaningful hair regrowth.
Topical GHK-Cu vs injectable GHK-Cu
Route of administration is an important distinction. Copper Tripeptide-1 is used in cosmetic skin-care products, and cosmetic safety assessments have concluded it is safe under the cosmetic-use conditions evaluated. That does not establish the safety of injected GHK-Cu. FDA states that compounded injectable GHK-Cu may pose immunogenicity risks related to aggregation and peptide-related impurities and that human safety data are limited.
Is GHK-Cu FDA-approved?
GHK-Cu is not an FDA-approved drug for anti-aging, wound healing, hair growth, recovery, or any other therapeutic indication. In the U.S. compounding process, FDA currently lists GHK-Cu for non-injectable routes as a bulk drug substance under evaluation. The injectable-route nomination was withdrawn, and FDA continues to publish specific safety concerns about compounded injectable GHK-Cu.
Current U.S. compounding status
FDA's May 2026 503A bulk-drug-substance update placed GHK-Cu, except for injectable routes, back into Category 1, meaning it remains under evaluation rather than being an approved bulk substance. FDA has said it intends to consult the Pharmacy Compounding Advisory Committee before the end of February 2027 regarding potential inclusion of non-injectable GHK-Cu on the 503A Bulks List.
What is known about GHK-Cu safety?
Safety evidence depends heavily on the route and formulation. Topical cosmetic use has a longer history and a different exposure profile than injection. For injectable GHK-Cu, FDA cites limited human data and potential concerns involving peptide aggregation, impurities, and immunogenicity. The absence of a well-defined human injectable safety profile also means that uncommon, delayed, route-specific, or cumulative adverse effects are not well characterized.
GHK-Cu and copper exposure
Because GHK-Cu contains copper, systemic exposure should not be treated as equivalent to ordinary topical cosmetic use. Copper is an essential trace element but is tightly regulated by the body, and excessive copper exposure can be harmful. There is not an established clinical literature defining safe long-term systemic GHK-Cu exposure in humans.
Research GHK-Cu vs cosmetic Copper Tripeptide-1
A cosmetic product listing Copper Tripeptide-1 and a vial marketed as research GHK-Cu are not equivalent products. They can differ in route, concentration, formulation, sterility requirements, manufacturing controls, intended use, and regulatory status. Evidence from topical cosmetics should not be used to establish the safety or effectiveness of an injectable research product.
GHK-Cu reconstitution math
Reconstitution calculations depend on the labeled amount in a vial and the liquid volume used. As a mathematical example, a 50mg vial combined with 5mL of liquid produces a concentration of 10mg per mL. BACToBasics uses examples like this only to demonstrate concentration, liquid-volume, and U-100 syringe-unit conversions rather than to provide a GHK-Cu dosing or preparation protocol.
Explore more about GHK-Cu
14 linksComparisons, research records, development tracking, blends, and related guides are available here when you want to go deeper.
Explore more about GHK-Cu
14 linksComparisons, research records, development tracking, blends, and related guides are available here when you want to go deeper.
Compare GHK-Cu
Direct comparison pages are selected from the indexable BACToBasics comparison catalog and update automatically as that catalog grows.
Research, updates & development
Jump from the guide into the public update timeline, compound-specific research records, and clinical-development tracker without searching again.
GHK-Cu research & development updates
Open the public timeline of sourced research records and material development changes tracked by BACToBasics.
Open →
ResearchGHK-Cu research sources
Open 2 curated research records for GHK-Cu.
Open →
DevelopmentGHK-Cu clinical development
Early human evidence — topical route · No established development program. Small randomized topical study after CO2 laser resurfacing.
Open →
Blend guides containing GHK-Cu
These pages are derived from blend component metadata, so a new blend automatically becomes discoverable from each linked component guide.
Related peptide guides
Related guides are ranked from shared comparison pages, shared blend pages, and peptide category rather than a hand-maintained link list.
BPC-157 guide & calculator
Recovery & Healing · Body Protection Compound 157
Open →
Peptide guideTB-500 guide & calculator
Recovery & Healing · Thymosin Beta-4 Fragment
Open →
Peptide guideKPV guide & calculator
Recovery & Healing · α-MSH-Derived Tripeptide
Open →
Peptide guideMT1 guide & calculator
Skin & Hair · Melanotan I / Afamelanotide / MC1 Receptor Agonist
Open →
Relevant glossary concepts
Definitions are matched against the guide's structured title, subtitle, description, and educational sections.
FDA-Approved
A status indicating that the FDA has approved a specific drug product for one or more labeled uses after reviewing the required evidence and manufacturing information.
Open →
GlossaryMilliliter (mL)
A metric unit of liquid volume equal to one-thousandth of a liter.
Open →
GlossaryConcentration
The amount of a substance contained in a given volume of liquid, such as mg/mL or mcg/mL.
Open →
GHK-Cu FAQ
Tap a question to expand only the answer you want to read.
Is GHK-Cu FDA-approved?
No. GHK-Cu is not an FDA-approved drug for skin rejuvenation, wound healing, hair growth, recovery, or another therapeutic indication.
Is GHK-Cu the same as Copper Tripeptide-1?
Copper Tripeptide-1 is the cosmetic ingredient name commonly used for the copper complex of GHK. In practice the terms are often used for the same copper-bound tripeptide, although product formulation and purity can differ substantially.
Does GHK-Cu increase collagen?
Human-fibroblast laboratory studies have reported increased collagen synthesis after GHK-Cu exposure. That supports a biological mechanism but does not prove that every topical or injectable GHK-Cu product will increase visible collagen or improve skin clinically.
Does GHK-Cu reduce wrinkles?
Direct controlled human evidence is limited. A small randomized post-laser study did not find an objective difference in wrinkles or overall skin quality, although patient satisfaction was higher in the GHK-Cu group.
Does GHK-Cu help wounds heal?
GHK-Cu has substantial laboratory and animal research involving wound-healing pathways, but large high-quality human trials proving faster or better wound healing are lacking.
Does GHK-Cu regrow hair?
There is not strong clinical evidence establishing GHK-Cu as a treatment for hair loss. Some frequently cited experiments involve related copper peptides or laboratory hair-follicle models rather than controlled trials showing meaningful hair regrowth in people.
Is topical GHK-Cu the same as injectable GHK-Cu?
No. The route, exposure, formulation, sterility requirements, and safety evidence are different. Topical cosmetic evidence should not be used to establish the safety of injected GHK-Cu.
Is injectable GHK-Cu safe?
A reliable human injectable safety profile has not been established. FDA has specifically cited limited human data and potential immunogenicity concerns related to aggregation and peptide-related impurities for compounded injectable GHK-Cu.
Can GHK-Cu cause copper toxicity?
Copper is an essential nutrient but can be harmful in excess. There is not enough human research to define the long-term systemic safety of injected GHK-Cu or to establish a cumulative exposure threshold for this use.
What is the current compounding status of GHK-Cu?
As of FDA's May 2026 update, GHK-Cu for non-injectable routes is in Category 1 of the 503A nomination process, meaning it is under evaluation. The injectable-route nomination was withdrawn and FDA separately lists safety concerns for compounded injectable GHK-Cu.
How do you calculate GHK-Cu reconstitution concentration?
Divide the labeled vial amount by the liquid volume. For example, 50mg divided by 5mL equals 10mg per mL. This is concentration math rather than a recommendation for how GHK-Cu should be prepared.
Can the BACToBasics calculator handle GHK-Cu math?
Yes. Enter a labeled vial amount and liquid volume to calculate concentration, equivalent liquid volume, U-100 syringe units, and approximate amounts per vial. BACToBasics provides educational math rather than dosing advice.
Sources & References
6 sourcesOpen the references when you want to inspect the research and regulatory sources behind this guide.
Sources & References
6 sourcesOpen the references when you want to inspect the research and regulatory sources behind this guide.
FDA states that compounded injectable GHK-Cu may pose immunogenicity risk due to aggregation and peptide-related impurities and that human safety data are limited.
FDA's current 503A nomination document lists GHK-Cu, except for injectable routes, in Category 1 under evaluation and explains the 2026 nomination changes.
Small randomized human study in 13 participants. Objective skin outcomes did not significantly differ between groups, while patient-reported skin-quality satisfaction favored the GHK-Cu regimen.
Laboratory study in human fibroblasts reporting increased collagen synthesis after exposure to the GHK-Cu complex.
Human-fibroblast culture study reporting increased synthesis of selected extracellular-matrix glycosaminoglycans.
Cosmetic safety review concluding Copper Tripeptide-1 is safe in cosmetics under the practices of use and concentrations evaluated; this conclusion does not address injectable use.
BACToBasics provides educational information and math tools only. This content is not medical advice, dosing advice, injection instruction, or a recommendation to use any peptide or medication.